Home  »  Finance   »  Analysts Mean recommendation for Sage Therapeutics...

Analysts Mean recommendation for Sage Therapeutics Inc. (SAGE) was 2.30: Is this the key time?

Sage Therapeutics Inc. (SAGE) is priced at $45.04 after the most recent trading session. At the very opening of the session, the stock price was $42.48 and reached a high price of $45.64, prior to closing the session it reached the value of $42.66. The stock touched a low price of $42.20.Recently in News on January 8, 2023, Sage Therapeutics to Provide Update on 2023 Key Initiatives at 41st Annual J.P. Morgan Healthcare Conference. Robust pipeline provides potential for long-term value creation, establishing Sage as a leader in brain health. You can read further details here

Sage Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $49.56 on 01/13/23, with the lowest value was $36.91 for the same time period, recorded on 01/03/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Sage Therapeutics Inc. (SAGE) full year performance was 17.87%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sage Therapeutics Inc. shares are logging -9.12% during the 52-week period from high price, and 64.62% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $27.36 and $49.56.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 527862 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Sage Therapeutics Inc. (SAGE) recorded performance in the market was 18.09%, having the revenues showcasing 24.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.68B, as it employees total of 471 workers.

Sage Therapeutics Inc. (SAGE) in the eye of market guru’s

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 39.13, with a change in the price was noted +6.90. In a similar fashion, Sage Therapeutics Inc. posted a movement of +18.09% for the period of last 100 days, recording 473,258 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SAGE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Sage Therapeutics Inc. (SAGE): Stocks Technical analysis and Trends

Raw Stochastic average of Sage Therapeutics Inc. in the period of last 50 days is set at 72.14%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.27%. In the last 20 days, the company’s Stochastic %K was 51.48% and its Stochastic %D was recorded 48.23%.

If we look into the earlier routines of Sage Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 18.09%. Additionally, trading for the stock in the period of the last six months notably improved by 31.24%, alongside a boost of 17.87% for the period of the last 12 months. The shares increased approximately by 2.27% in the 7-day charts and went down by 13.08% in the period of the last 30 days. Common stock shares were driven by 24.52% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts